|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002871,
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0237401,
umls-concept:C0936012,
umls-concept:C0937950,
umls-concept:C1511726,
umls-concept:C1709595,
umls-concept:C2349200
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
2009-6-9
|
|
pubmed:abstractText |
Although numerous clinical trials have demonstrated the efficacy and tolerability of erythropoiesis-stimulating agents (ESAs) in patients with chemotherapy-induced anemia (CIA), results of some recent trials and one meta-analysis have suggested that ESAs may negatively impact survival and/or disease control in patients with cancer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2838-47
|
|
pubmed:dateRevised |
2009-11-23
|
|
pubmed:meshHeading |
pubmed-meshheading:19380447-Anemia,
pubmed-meshheading:19380447-Antineoplastic Agents,
pubmed-meshheading:19380447-Blood Transfusion, Autologous,
pubmed-meshheading:19380447-Clinical Trials as Topic,
pubmed-meshheading:19380447-Disease-Free Survival,
pubmed-meshheading:19380447-Drug Therapy,
pubmed-meshheading:19380447-Drug Toxicity,
pubmed-meshheading:19380447-Erythropoietin,
pubmed-meshheading:19380447-Female,
pubmed-meshheading:19380447-Hemoglobins,
pubmed-meshheading:19380447-Humans,
pubmed-meshheading:19380447-Male,
pubmed-meshheading:19380447-Randomized Controlled Trials as Topic,
pubmed-meshheading:19380447-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia.
|
|
pubmed:affiliation |
Wilhelminenspital, Department of Medicine I, Center for Oncology and Hematology, Pavillion 23, Montleartstrasse 37, Vienna 1160, Austria. heinz.ludwig@wienkav.at
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
